InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.11
(
-0.02%
)
Bitcoin
63,986.48
(
-0.02%
)
Post# of 251721
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

hiwatt1959

Send PM Follow Ignore
Followers 0
Posts 31
Boards Moderated 0
Alias Born 10/25/2016

hiwatt1959

Re: DewDiligence post# 208667

Sunday, 02/26/2017 5:38:41 PM

Sunday, February 26, 2017 5:38:41 PM

Post# of 251721
With new ceo at Rprx, with EU day 120 update on Androxal due any day now, with one year P2B on Androxal due any day, with Proellex going before FDA in April for P3 guidance, With Allergan just completing a successful P3 on Esmya (SPRM), do you have an opinion on whether they can get stock price up enough to get a decent buy out offer. Cash should last to mid year since they have completed all studies
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up